Acne vulgaris (acne) is currently one of the most common and well established dermatology conditions, affecting around 90% of the world’s population at some point in their lifetime.  According to current literature, acne is often a result of a disturbed balance in the microbiome, where the pathogenic Cutibacterium acnes (C. acnes) grow and thrive.

Solutions

Lactobacillus plantarum LB356R® and LB356R® Ferment lysate have the ability to co-aggregate with the pathogenic ribotypes of C. acnes and thereby inhibit the growth of pathogenic C acnes and biofilm formation resulting in acne vulgaris.

Read more about our research and solutions for acne vulgaris here.